Express Pharma

PharmEasy plans $200 million fund raising at lower valuation

Signalling growing stress in India's startup ecosystem, one source said PharmEasy, backed by big-name investors such as Prosus, TPG and Temasek, is in talks to secure the new funds at a valuation as much as 15 per cent below last year's

0 186